These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
88. Spironolactone for the treatment of PMS. Hendler N Md Med J; 1992 Apr; 41(4):286. PubMed ID: 1569834 [No Abstract] [Full Text] [Related]
89. Allopregnanolone decrease with symptom improvement during placebo and gonadotropin-releasing hormone agonist treatment in women with severe premenstrual syndrome. Nyberg S; Bäckström T; Zingmark E; Purdy RH; Poromaa IS Gynecol Endocrinol; 2007 May; 23(5):257-66. PubMed ID: 17558683 [TBL] [Abstract][Full Text] [Related]
90. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Redei E; Freeman EW Psychoneuroendocrinology; 1995; 20(3):259-67. PubMed ID: 7777654 [TBL] [Abstract][Full Text] [Related]
91. Hormonal management of premenstrual syndrome. Usman SB; Indusekhar R; O'Brien S Best Pract Res Clin Obstet Gynaecol; 2008 Apr; 22(2):251-60. PubMed ID: 17761457 [TBL] [Abstract][Full Text] [Related]
92. Vasopressin and prostaglandins in premenstrual pain and primary dysmenorrhea. Strömberg P; Akerlund M; Forsling ML; Granström E; Kindahl H Acta Obstet Gynecol Scand; 1984; 63(6):533-8. PubMed ID: 6542295 [TBL] [Abstract][Full Text] [Related]
93. Oral contraceptives containing drospirenone for premenstrual syndrome. Ma S; Song SJ Cochrane Database Syst Rev; 2023 Jun; 6(6):CD006586. PubMed ID: 37365881 [TBL] [Abstract][Full Text] [Related]
94. Efficacy of Treatments Targeting Hypothalamic-Pituitary-Adrenal Systems for Major Depressive Disorder: A Meta-Analysis. Ding Y; Wei Z; Yan H; Guo W Front Pharmacol; 2021; 12():732157. PubMed ID: 34566653 [TBL] [Abstract][Full Text] [Related]
95. New Pharmacological Interventions in Bipolar Disorder. Juruena MF; Jelen LA; Young AH; Cleare AJ Curr Top Behav Neurosci; 2021; 48():303-324. PubMed ID: 33547595 [TBL] [Abstract][Full Text] [Related]
96. The Association Between Vascular Inflammation and Depressive Disorder. Causality, Biomarkers and Targeted Treatment. Kalkman HO Pharmaceuticals (Basel); 2020 May; 13(5):. PubMed ID: 32408603 [TBL] [Abstract][Full Text] [Related]
97. Criteria for premenstrual dysphoric disorder: secondary analyses of relevant data sets. Hartlage SA; Freels S; Gotman N; Yonkers K Arch Gen Psychiatry; 2012 Mar; 69(3):300-5. PubMed ID: 22393222 [TBL] [Abstract][Full Text] [Related]
98. Premenstrual syndrome: approaches to diagnosis and treatment. Simkin RJ Can Fam Physician; 1985 Oct; 31():1959-67. PubMed ID: 21274209 [TBL] [Abstract][Full Text] [Related]
99. Safety, efficacy, actions, and patient acceptability of drospirenone/ethinyl estradiol contraceptive pills in the treatment of premenstrual dysphoric disorder. Breech LL; Braverman PK Int J Womens Health; 2010 Aug; 1():85-95. PubMed ID: 21072278 [TBL] [Abstract][Full Text] [Related]
100. Update on research and treatment of premenstrual dysphoric disorder. Cunningham J; Yonkers KA; O'Brien S; Eriksson E Harv Rev Psychiatry; 2009; 17(2):120-37. PubMed ID: 19373620 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]